Cold War tensions and the polio vaccine was the first polio vaccine to receive approval of the U.S. government, and was used until 1961 in America, when the Sabin vaccine was recommended to replace it. Albert Sabin, a virologist who publicly disagreed with Salk and his killed vaccine, worked on creating a vaccine with live, attenuated vaccines. Despite Cold War tensions, in January, 1956 Mikhail Chumakov, the director of Moscow's Polio Research Institute, his wife and colleague Marina Voroshilova, and Anatoli Smorodentsev, traveled to the U.S. in order to study the Salk vaccine and visited the laboratory of Albert Sabin. With the clearance of the FBI, Sabin
Influenza vaccine sera (chiefly against what we now call "Hemophilus influenzae"—a name derived from the fact that it was originally considered the etiological agent—and several types of pneumococci). Only one therapeutic measure, transfusing blood from recovered patients to new victims, showed any hint of success." In 1931, viral growth in embryonated hens' eggs was reported by Ernest William Goodpasture and colleagues at Vanderbilt University. The work was extended to growth of influenza virus by several workers, including Thomas Francis, Jonas Salk, Wilson Smith and Macfarlane Burnet, leading to the first experimental influenza vaccines. In the 1940s, the US military developed the first